Manulife (Manufacturers Life Insurance)
CADL icon

Manulife (Manufacturers Life Insurance)’s Candel Therapeutics CADL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.7K Sell
12,993
-615
-5% -$3.35K ﹤0.01% 2703
2025
Q4 		$76.9K Sell
13,608
-121
-0.9% -$651 ﹤0.01% 2763
2025
Q3 		$70K Sell
13,729
-97
-0.7% -$561 ﹤0.01% 2843
2025
Q2 		$70K Buy
+13,826
New +$71.2K ﹤0.01% 2835

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CADL Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Candel Therapeutics (CADL) stake by 4.5% in Q1 2026, selling an estimated $3.35K and leaving 12,993 shares worth $63.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

Manulife (Manufacturers Life Insurance) first reported a position in CADL in Q2 2025 and has held it in 4 quarters since. The position peaked at $76.9K in Q4 2025. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 12,993 shares of Candel Therapeutics worth $63.7K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 615 Candel Therapeutics shares in Q1 2026, an estimated $3.35K.
  • Candel Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2703 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Candel Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Candel Therapeutics position peaked at $76.9K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.